3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rare Diseases
1
Neoplasm, Residual
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Genetic Predisposition to Disease
1
Interventions
Metformin
2
Clomiphene
2
Propofol
1
Prednisone
1
Midazolam
1
Leuprolide
1
Immunoglobulins
1
High-Throughput Nucleotide Sequencing
1
Fentanyl
1
Cyclophosphamide
1
Amifampridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Rare Diseases
×
High-Throughput Nucleotide Sequencing
×
Clear all
NCT06060184
2023-09-29
IonGER
University Hospital Tuebingen
Phase NA
Not yet recruiting
500 enrolled